China Pharma Holdings, Inc. SEC filings CPHI
China Pharma Holdings, Inc. has 426 filings in SEC EDGAR's recent list, going back to Feb 15, 2000. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 22, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Notification of late filing | Apr 1, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 18, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2023 | — |
| CORRESP | Letter to the SEC | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2023 | — |
| D | Filing | Nov 29, 2021 | — |
| EFFECT | Filing | Jan 21, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2021 | — |
| DEFA14C | China pharma holdings | Nov 21, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2012 | — |
| CORRESP | Letter to the SEC | Mar 6, 2012 | — |
| CORRESP | Letter to the SEC | Feb 28, 2012 | — |
| CORRESP | Letter to the SEC | Feb 13, 2012 | — |
| CORRESP | Letter to the SEC | Jan 17, 2012 | — |
| CORRESP | Letter to the SEC | Dec 29, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2011 | — |
| CORRESP | Letter to the SEC | Nov 17, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2011 | — |
| CORRESP | Letter to the SEC | Oct 24, 2011 | — |
| CORRESP | Letter to the SEC | Sep 23, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2011 | — |
| CORRESP | Letter to the SEC | Aug 19, 2011 | — |
| CORRESP | Letter to the SEC | Aug 16, 2011 | — |
| CORRESP | Letter to the SEC | Aug 3, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2011 | — |
| UPLOAD | Letter from the SEC | May 3, 2010 | — |
| PRER14C | China pharma holdings, inc. | Apr 30, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2010 | — |
| CORRESP | Letter to the SEC | Apr 22, 2010 | — |
| PRER14C | China pharma holdings, inc. | Apr 22, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2010 | — |
| EFFECT | Filing | Feb 24, 2010 | — |
| EFFECT | Filing | Jan 15, 2010 | — |
| CORRESP | Letter to the SEC | Jan 12, 2010 | — |
| CORRESP | Letter to the SEC | Jan 12, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 7, 2010 | — |
| CERTNYS | Auto-generated paper document | Sep 29, 2009 | — |
| 8-A12B | Filing | Sep 28, 2009 | — |
| DEFR14C | Filing | Sep 23, 2009 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2009 | — |
| CORRESP | Letter to the SEC | Jun 24, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2009 | — |
| CORRESP | Letter to the SEC | Mar 12, 2009 | — |
| 10KSB/A | Filing | Mar 12, 2009 | Dec 31, 2007 |
| UPLOAD | Letter from the SEC | Dec 23, 2008 | — |
| EFFECT | Filing | Aug 12, 2008 | — |
| CORRESP | Letter to the SEC | Aug 7, 2008 | — |
| 10QSB | Filing | Aug 5, 2008 | Jun 30, 2008 |
| CORRESP | Letter to the SEC | Aug 4, 2008 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2008 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2008 | — |
| CORRESP | Letter to the SEC | Jul 10, 2008 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2008 | — |
| 10QSB | Filing | Apr 30, 2008 | Mar 31, 2008 |
| 10KSB | Filing | Mar 31, 2008 | Dec 31, 2007 |
| 10QSB | Filing | Nov 14, 2007 | Sep 30, 2007 |
| 10QSB | Filing | Aug 13, 2007 | Jun 30, 2007 |
| 10QSB | Filing | May 15, 2007 | Mar 31, 2007 |
| EFFECT | Filing | May 4, 2007 | — |
| CORRESP | Letter to the SEC | May 3, 2007 | — |
| SB-2/A | Filing | Apr 24, 2007 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2007 | — |
| SB-2/A | Filing | Apr 3, 2007 | — |
| SB-2 | Filing | Mar 30, 2007 | — |
| 10KSB | Filing | Mar 28, 2007 | Dec 31, 2006 |
| 10QSB | Filing | Nov 13, 2006 | Sep 30, 2006 |
| 10KSB/A | Filing | Nov 8, 2006 | Dec 31, 2005 |
| 10QSB | Filing | Aug 14, 2006 | Jun 30, 2006 |
| 10QSB | Filing | May 15, 2006 | Mar 31, 2006 |
| 10KSB | Filing | Mar 31, 2006 | Dec 31, 2005 |
| PRER14C | Schedule 14c - amendment no. 1 | Mar 15, 2006 | — |
| CORRESP | Letter to the SEC | Feb 1, 2006 | — |
| CORRESP | Letter to the SEC | Jan 25, 2006 | — |
| SB-2/A | Filing | Dec 23, 2005 | — |
| 10QSB | Filing | Nov 18, 2005 | Sep 30, 2005 |
| SB-2/A | Filing | Nov 16, 2005 | — |
| NT 10-Q | Filing | Nov 14, 2005 | Sep 30, 2005 |
| UPLOAD | Letter from the SEC | Oct 26, 2005 | — |
| SB-2 | Filing | Oct 20, 2005 | — |
| 10KSB | Filing | Sep 23, 2005 | Jun 30, 2005 |
| CORRESP | Letter to the SEC | Aug 23, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2005 | — |
| 10QSB | Filing | May 9, 2005 | Mar 31, 2005 |
| 10QSB | Filing | Feb 22, 2005 | Dec 31, 2004 |
| NT 10-Q | Filing | Feb 14, 2005 | Dec 31, 2004 |
| 10QSB | Filing | Nov 24, 2004 | Sep 30, 2004 |
| NT 10-Q | Ts electronics nt-10q 9-30-04 | Nov 15, 2004 | Sep 30, 2004 |
| NTN 10Q | Ts electronics, inc. nt-10q 9-30-04 | Nov 15, 2004 | Aug 30, 2004 |
| 10KSB | Ts electronics 10ksb 6-30-04 | Oct 14, 2004 | Jun 30, 2004 |
| NT 10-K | Ts electronics, inc. nt 10k 6-30-04 | Sep 27, 2004 | Jun 30, 2004 |
| 10QSB | Filing | May 17, 2004 | Mar 31, 2004 |
| 10KSB/A | Filing | Mar 25, 2004 | Jun 30, 2003 |
| 10QSB | Filing | Feb 18, 2004 | Dec 31, 2003 |
| NT 10-Q | Filing | Feb 17, 2004 | Dec 31, 2003 |
| AW | Filing | Jan 20, 2004 | — |
| 10KSB/A | Filing | Dec 8, 2003 | Jun 30, 2003 |
| PRER14C | Filing | Dec 8, 2003 | — |
| 10QSB | Filing | Nov 19, 2003 | Sep 30, 2003 |
| NT 10-Q | Filing | Nov 17, 2003 | Sep 30, 2003 |
| 10KSB | Filing | Oct 14, 2003 | Jun 30, 2003 |
| PRER14C | Filing | Oct 10, 2003 | — |
| NT 10-K | Filing | Sep 25, 2003 | Jun 30, 2003 |
| 10KSB/A | Filing | Aug 29, 2003 | Jun 30, 2002 |
| 10QSB | Filing | May 20, 2003 | Mar 31, 2003 |
| NT 10-Q | Filing | May 16, 2003 | Mar 31, 2003 |
| 10QSB | Filing | Feb 19, 2003 | Dec 31, 2002 |
| NT 10-Q | Filing | Feb 13, 2003 | Dec 31, 2002 |
| 10KSB/A | Filing | Jan 27, 2003 | Jun 30, 2002 |
| 10QSB | Filing | Nov 19, 2002 | Sep 30, 2002 |
| NT 10-Q | Filing | Nov 12, 2002 | Sep 30, 2002 |
| 10KSB/A | Filing | Oct 21, 2002 | Jun 30, 2002 |
| 10KSB | Filing | Oct 15, 2002 | Jun 30, 2002 |
| NT 10-K | Filing | Sep 26, 2002 | Jun 30, 2002 |
| 10QSB | Filing | May 20, 2002 | Mar 31, 2002 |
| NT 10-Q | Filing | May 16, 2002 | Mar 31, 2002 |
| 10QSB | Filing | Feb 8, 2002 | Dec 31, 2001 |
| 10QSB | Filing | Nov 19, 2001 | Sep 30, 2001 |
| NT 10-Q | Filing | Nov 15, 2001 | Sep 30, 2001 |
| 10QSB | Filing | Aug 14, 2001 | Jun 30, 2001 |
| 10QSB | Kilkenny acquisition corp. | May 1, 2001 | Mar 31, 2001 |
| 10KSB | Kilkenny acquisition corp. | Mar 30, 2001 | Dec 31, 2000 |
| 10QSB | Kilkenny acquisition corporation | Nov 13, 2000 | Sep 30, 2000 |
| 10QSB | Kilkenny acquisition corporation | Aug 7, 2000 | Jun 30, 2000 |
| 10QSB | Kilkenny acquisition corporation | May 11, 2000 | Mar 31, 2000 |
| 10SB12G/A | Kilkenny acquisition corp. | Apr 21, 2000 | — |
| 10SB12G/A | Kilkenny acquisition corp. | Apr 4, 2000 | — |
| 10SB12G | Kilkenny acquisition corp. | Feb 15, 2000 | — |
Showing 135 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPHI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hainan Province, China
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1106644
- Former names
- TS ELECTRONICS INC (until May 4, 2006); SOFTSTONE INC (until Aug 18, 2003); SOFTSTONE INC /DE/ (until Jan 27, 2003); KILKENNY ACQUISITION CORP (until Mar 30, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.